cagrilintide semaglutide combination cagrisema phase 3 2025 Updates in Medicine | 🔬 REDEFINE 2: in T2D + Obesity Original article link in bio 👥 3a RCT in 1206 adults with T2D (BMI ≥27, HbA1c 7–10%) 💉 Cagrilintide–semaglutide (CagriSema) as an add-on

Stopping it does not fix them either

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (15-amino acid sequence) derived from a protective protein found in human gastric juice, where it functions to maintain mucosal integrity and promote gastrointestinal homeostasis

The acquisition of stable multi-compound formulations provides laboratories with the unprecedented capability to observe complex, overlapping regeneration pathways simultaneously

22 patients (73%) were being treated for PA 5 were being treated post surgery

Without adequate B12, these processes begin to function sub-optimally and the effects, while not always dramatic in the early stages, accumulate in ways that many people experience as persistent tiredness, reduced mental sharpness, lower mood and a general lack of the vitality they feel they should have